A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
Clinical trial NCT04324060 · UNKNOWN
Trial details
- NCT number
- NCT04324060
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.